Compare ICUI & ALHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICUI | ALHC |
|---|---|---|
| Founded | 1984 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.2B |
| IPO Year | 1992 | 2021 |
| Metric | ICUI | ALHC |
|---|---|---|
| Price | $145.24 | $19.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 11 |
| Target Price | ★ $183.60 | $19.77 |
| AVG Volume (30 Days) | 255.1K | ★ 2.3M |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,320,363,000.00 | ★ $3,637,156,000.00 |
| Revenue This Year | N/A | $48.51 |
| Revenue Next Year | N/A | $29.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 47.39 |
| 52 Week Low | $107.00 | $10.18 |
| 52 Week High | $175.51 | $21.06 |
| Indicator | ICUI | ALHC |
|---|---|---|
| Relative Strength Index (RSI) | 60.24 | 63.58 |
| Support Level | $141.10 | $19.02 |
| Resistance Level | $150.38 | $19.99 |
| Average True Range (ATR) | 5.06 | 0.70 |
| MACD | -0.76 | 0.10 |
| Stochastic Oscillator | 61.15 | 77.32 |
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.